Foresite Capital Management II as of Dec. 31, 2015
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 21 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 25.3 | $75M | 4.1M | 18.45 | |
| Aduro Biotech | 15.6 | $47M | 1.7M | 28.14 | |
| Adaptimmune Therapeutics (ADAP) | 7.1 | $21M | 1.8M | 12.06 | |
| Universal American | 6.6 | $20M | 2.8M | 7.00 | |
| Epizyme | 6.2 | $19M | 1.2M | 16.02 | |
| Aerie Pharmaceuticals | 6.0 | $18M | 738k | 24.35 | |
| Regulus Therapeutics | 5.1 | $15M | 1.8M | 8.72 | |
| Alder Biopharmaceuticals | 4.7 | $14M | 420k | 33.03 | |
| Orexigen Therapeutics | 3.6 | $11M | 6.2M | 1.72 | |
| Zafgen | 3.1 | $9.4M | 1.5M | 6.29 | |
| Ardelyx (ARDX) | 2.9 | $8.7M | 478k | 18.12 | |
| Nanostring Technologies (NSTGQ) | 2.4 | $7.2M | 490k | 14.71 | |
| BioDelivery Sciences International | 2.4 | $7.0M | 1.5M | 4.79 | |
| Anacor Pharmaceuticals In | 2.4 | $7.0M | 62k | 112.97 | |
| Acceleron Pharma | 2.2 | $6.7M | 138k | 48.76 | |
| Quotient | 1.0 | $3.1M | 192k | 16.00 | |
| Nexvet Biopharma Pub Ltd Co ord | 1.0 | $3.0M | 874k | 3.41 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $2.6M | 157k | 16.60 | |
| Scynexis | 0.7 | $2.1M | 337k | 6.21 | |
| Axovant Sciences | 0.4 | $1.2M | 65k | 18.03 | |
| Neuroderm Ltd F | 0.3 | $951k | 56k | 17.05 |
